Essential Fatty Acids in Health and Disease

Journal of Association of Physicians of India

Volumn 47, Issue 9, 1999, Pages 906-911

  Das, U N ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID;

CELL MEMBRANE; HUMAN; NUTRITIONAL REQUIREMENT; PHYSIOLOGY; REVIEW;

CELL MEMBRANE; FATTY ACIDS, ESSENTIAL; HUMANS; NUTRITIONAL REQUIREMENTS;

EID: 0033186851     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Das UN. Essential fatty acids : Biology and their clinical implications. Asia Pacific J Pharmacol 1991; 6 : 317-30.
2. Das UN, Horrobin DF, Begin ME, et al. Clinical significance of essential fatty acids. Nutrition 1988; 4 : 337-41.
3. Horrobin DF. The regulation of prostagland in biosynthesis by the manipulation of essential fatty acid metabolism. Review Pure Appl Pharmacol Sci 1983; 4 : 339-83.
4. Brenner RR. Nutritional and hormonal factors influencing desaturation of essential fatty acids. Prog Lipid Res 1982; 20 : 41-8.
5. Das UN. Insulin resistance and hyperinsulinemia : Are they secondary to an alteration in the metabolism of essential fatty acids. Med Sci Res 1994; 22 : 243-5.
6. Das UN. Nutrients, essential fatty acids and prostaglandins interact to augment immune responses and prevent genetic damage and cancer. Nutrition 1989; 5 : 106-10.
7. Das UN, Devi GR, Rao KP, Rao MS. Prostaglandins and their precursors can modify genetic damage induced by benzo(a) pyrene and gamma-radiation. Prostaglandins 1985; 29 : 911-20.
8. FAO/WHO. Dietary fats and oils in human nutrition. FAO Food Nutrition paper. 1977; 3.
9. McPhail LC, Clayson CC, Snyderman R. A Potential second messenger role for unsaturated fatty acids : activation of Ca dependent protein kinase. Science 1984; 224 : 622-5.
10. Berridge MJ, Irwin RF. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312 : 693-8.
11. Sangeetha PS, Das UN, Koratkar R. Free radical generation in human leukocytes by cis-unsaturated fatty acids is a calmodulin dependent process. Prostaglandins Leukotrienes Essential Fatty Acids 1990; 39 : 27-30.
12. Das UN. Antibiotic-like actions of essential fatty acids. Cannadian Med Assoc J 1985; 132 : 1350.
13. Seaman WE, Stobo JD. Human and murine natural killer cell activity may require lipoxygenation of arachidonic acid. J Allergy Clin Immunol 1984; 74 : 407-11.
14. Schlager SI, Meltzer MS. Role of macrophage lipids in regulating tumoricidal activity. Cell Immunol 1983; 80 : 10-9.
15. Schlager SI, Madden LD, Meltzer MS. Role of macrophage lipids in regulating tumoricidal activity. Cell Immunol 1983; 77 : 52-68.
16. Santoli D, Phillips PD, Colt TL, et al. Suppression of interleukin-2 dependent T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. J Clin Invest 1990; 85 : 424-32.
17. Sravan Kumar G, Das UN, Vijay Kumar K, et al. Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutrition Res 1992; 12 : 815-23.
18. Das UN, Devi GR, Rao KP, et al. Prostaglandins can modify gamma-radiation and chemical-induced cytotoxicity and genetic damage in vitro and in vivo. Prostaglandins 1989; 39:689-716.
19. Begin ME, Das UN, Ells G, Horrobin DF. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukotrienes Med 1985; 19 : 177-86.
20. Das UN. Gamma-linolenic acid, arachidonic acid and eicosapentaenoic acid as potential anti-cancer drugs. Nutrition 1990; 6 : 429-34.
21. Das UN. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett 1991; 56 : 235-43.
22. Sangeetha PS, Das UN. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukotrienes Essential Fatty Acids 1995; 53 : 287-99.
23. Sangeetha PS, Das UN. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells : relationship to free radicals and lipid peroxidation and its modulation by calmodulin antagonists. Cancer Lett 1992; 63 : 189-98.
24. Sravan Kumar G, Das UN. Free radical dependent suppression of growth of mouse myeloma cells by alpha linolenic acid and eicosapentaenoic acid in vitro. Cancer Lett 1995; 92 : 27-38.
25. Das UN. Cis-unsaturated fatty acids as potential anti-mutagenic, tumoricidal and anti-metastatic agents. Asia Pacific J Pharmacol 1992; 7 : 305-27.
26. Padma M, Das UN. Effect of cis-unsaturated fatty acids on cellular oxidant stress in macrophage tumor (AK-5) cells in vitro. Cancer Lett 1996; 109 : 63-75.
27. Madhavi N, Das UN. Effect of n-6 and n-3 fatty acids on the survival of vincristine sensitive and resistant human cervical carcinoma cells in vitro. Cancer Lett 1994; 84 : 31-41.
28. R-8-5 tumor cell drug-resistance by cis-unsaturated fatty acids in vitro. Med Sci Res 1994; 22 : 689-92.
29. Ramesh G, Das UN. Effect of dietary fat on diethylnitrosamine induced hepatocarcinogenesis in Wistar rats. Cancer Lett 1995; 95 : 237-45.
30. Ramesh G, Das UN. Effect of free fatty acids on two-stage skin carcinogenesis in mice. Cancer Lett 1996; 100 : 199-209.
31. Seigel I, Liu TL, Yaghoubzadeh E, Kashey TS, Gleicher N. Cytotoxic effects of free fatty acids on ascites tumour cells. J Natl Cancer Inst 1987; 78 : 271-7.
32. Naidu MRC, Das UN, Kishan A. Intra-tumoral gamma-linolenic acid therapy of human glioma. Prostaglandins Leukotirenes Essential Fatty Acids 1992; 45 : 181-4.
33. Das UN, Prasad VVSK, Reddy DR. Local application of gamma-linolenic acid in the treatment of human gliomas. Cancer Lett 1995; 94 : 147-55.
34. Das UN. Tumoricidal action of gamma-linolenic acid with particular reference to the therapy of human gliomas. Med Sci Res 1995; 23: 507-13.
35. Cornwell DG, Rao VP. Atherosclerosis : An intracellular deficiency of essential fatty acids. Prog Lipid Res 1981; 20 : 365-76.
36. Vijay Kumar K, Das UN. Effect of cis-unsaturated fatty acids, prostaglandins, and free radicals on angiotensin-converting enzyme activity in vitro. Proc Soc Exp Biol Med (in press).
37. Kohn A, Gitelman J, Inbar M. Unsaturated free fatty acids inactivate animal enveloped viruses. Arch Virol 1980; 66 : 301-7.
38. Das UN. Beneficial action(s) of eicosapentaenoic acid/docosahexaenoic and nitric oxide in systemic lupus erythematosus. Med Sci Res 1995; 23 : 723-6.
39. Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet 1985; ii : 373-7.
40. Naughton JM. Supply of polyenoic fatty acids to mammalian brain. J Biochem 1981; 13 : 21-2.
41. Houtsmuller AJ. Significance of linoleic acid in the metabolism and therapy of diabetes mellitus. World Rev Nutrition Dietics 1982; 39 : 85-123.
42. Wright S, Burton JL. Oral evening primrose oil improves atopic eczema. Lancet 1982; ii : 1120-2.
43. Goolamali SK, Shuster S. A sebotrophic stimulus in benign and malignant breast disease. Lancet 1975; i : 428-9.
44. Goodfriend TL, Ball DL. Fatty acid effects on angiotensin receptors. J Cardiovas Pharmacol 1986; 8 : 1276-83.
45. Das UN, Kumari S, Sahay BK, Rao MH. Beneficial effect of essential fatty acids in cirrhosis of the liver. J Assoc Physicians India 1987; 35 : 139-40.
46. Editorial. Eskimo diets and diseases. Lancet 1983; i : 1139-40.
47. Mohan IK, Das UN. Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandian Leukotrienes Essential Fatty Acids 1997; 56 : 193-8.
48. Das UN, Kumar KV, Madhavi N, et al. Psoriasis : Current concepts and new approaches to therapy. Med Hypotheses 1992; 38 : 56-62.
49. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukotrienes Essential Fatty Acids 1995; 52 : 287-91.
50. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukotriener Essential Fatty Acids 1995; 52 : 387-91.